Single Lab Test

Collagen-binding Activity (CBA / vWF Collagen Binding Activity) Profile

Back to Search
Categories
Turnaround Time
4 - 9 days
CPT Code
8,524,683,520
Test Type

2 mL Plasma, frozen

Overview

Screen for the presence of type II von Willebrand disease in plasma6.

vWF is an acute phase reactant protein and levels may be increased transiently into the normal range in some individuals with mild vWD following adrenergic stimulation or in response to certain drug therapies such as DDAVP or estrogen.

This procedure may be considered by Medicare and other carriers as investigational and, therefore, may not be payable as a covered benefit for patients.

The collagen binding assay (CBA) can aid in the differentiation between von Willebrand disease type I and type II when used in conjunction with the vWF antigen assay. This assay evaluates the ability of high molecular weight multimers present in the patient's sample to bind collagen which is coated on the microtiter plates. The amount of vWF bound is measured using peroxidase-conjugated antibodies to human vWF. Following the addition of substrate, color intensity is proportional to the high molecular weight multimers present in the sample. Results are expressed as percent collagen-binding activity and also as a ratio of percent collagen-binding activity to total vWF antigen. The CBA activity correlates more closely with vWF function and bleeding problems than ELISA for vWF antigen levels.

1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol. 1997 Jan; 107(1):105-110. PubMed 8980376

2. Reneke J, Etzell J, Leslie S, Ng VL, Gottfried EL. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998 Jun; 109(6):754-757. PubMed 9620035

3. National Committee for Clinical Laboratory Standardization. Collection, Transport, and Processing of Blood Specimens for Coagulation Testing and General Performance of Coagulation Assays; Approved Guideline. 5th ed. Villanova, Pa: NCCLS; 2008. Document H21-A5:28(5).

4. Gottfried EL, Adachi MM. Prothrombin time and activated partial thromboplastin time can be performed on the first tube. Am J Clin Pathol. 1997 Jun; 107(6):681-683. PubMed 9169665

5. McGlasson DL, More L, Best HA, Norris WL, Doe RH, Ray H. Drawing specimens for coagulation testing: Is a second tube necessary? Clin Lab Sci. 1999 May-Jun; 12(3):137-139. PubMed 10539100

6. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995 Oct; 74(4):1185-1190. PubMed 8560433

Collection Details

Patient Preparation:

Collection Instructions:

Discover the Evexia advantage

Start Ordering Today

Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.